Altered microRNA expression in mycosis fungoides

British Journal of Dermatology

Volumn 166, Issue 2, 2012, Pages 331-336

  Maj, J ^a   Jankowska Konsur, A ^a   Sadakierska Chudy, A ^a,b   Noga, L ^a   Reich, A ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

LET 7A PROTEIN; LET 7D PROTEIN; LET 7F PROTEIN; MICRORNA; MICRORNA 155; MICRORNA 15A; MICRORNA 16; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EARLY CANCER; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PROGNOSIS; RNA ANALYSIS; RNA ISOLATION; SKIN BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM METASTASIS; PROGNOSIS; SKIN NEOPLASMS;

EID: 84856235772     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10669.x     Document Type: Article

References (43)

1. Alibert JLM,. Tableau du Plan Fongoide: Descriptions des Maladies de la Peau Observées à l'Hôpital Saint-Louis, et Exposition des Meilleures Méthodes Suivies pour leur Traitement. Paris: Barrois l'Aîné et Fils, 1806.
2. Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organization for Research and Treatment of Cancer staging proposal. J Clin Oncol 2010; 28: 4730-9.
3. Ohtani K, Dimmeler S,. Control of cardiovascular differentiation by microRNAs. Basic Res Cardiol 2011; 106: 5-11.
4. Bhagavathi S, Czader M,. MicroRNAs in benign and malignant hematopoiesis. Arch Pathol Lab Med 2010; 134: 1276-81.
5. Ivey KN, Srivastava D,. MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell 2010; 7: 36-41.
6. Moore KJ, Rayner KJ, Suárez Y, Fernández-Hernando C,. MicroRNAs and cholesterol metabolism. Trends Endocrinol Metab 2010; 21: 699-706.
7. Zanette DL, Rivadavia F, Molfetta GA, et al. MiRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res 2007; 40: 1435-40.
8. Roman-Gomez J, Agirre X, Jiménez-Velasco A, et al. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. J Clin Oncol 2009; 27: 1316-22.
9. Malumbres R, Sarosiek KA, Cubedo E, et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 2009; 113: 3754-64.
10. Navarro A, Beà S, Fernández V, et al. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas. Cancer Res 2009; 69: 7071-8.
11. Navarro A, Gaya A, Martinez A, et al. MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 2008; 111: 2825-32.
12. Robertus JL, Kluiver J, Weggemans C, et al. MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma. Br J Haematol 2010; 149: 896-9.
13. Ballabio E, Mitchell T, van Kester MS, et al. MicroRNA expression in Sézary syndrome: identification, function, and diagnostic potential. Blood 2010; 116: 1105-13.
14. van Kester MS, Ballabio E, Benner MF, et al. miRNA expression profiling of mycosis fungoides. Mol Oncol 2011; 5: 273-80.
15. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713-22.
16. Wilson KD, Venkatasubrahmanyam S, Jia F, et al. MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev 2009; 18: 749-58.
17. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-81.
18. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
19. Calin GA, Dumitru CD, Shumizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-9.
20. Bonci D, Coppola V, Musumeci M, et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008; 14: 1271-7.
21. Bottoni A, Piccin D, Tagliati F, et al. miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol 2005; 204: 280-5.
22. Finnerty JR, Wang WX, Hébert SS, et al. The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol 2010; 402: 491-509.
23. Faraoni I, Antonetti FR, Cardone J, Bonmassar E,. miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 2009; 1792: 497-505.
24. O'Connell RM, Kahn D, Gibson WS, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010; 33: 607-19.
25. Linnstaedt SD, Gottwein E, Skalsky RL, et al. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol 2010; 84: 11670-8.
26. Tili E, Michaille JJ, Cimino A, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007; 179: 5082-9.
27. Nikiforova MN, Tseng GC, Steward D, et al. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 2008; 93: 1600-8.
28. Lee EJ, Gusev Y, Jiang J, et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 2007; 120: 1046-54.
29. Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065-70.
30. Kluiver J, Poppema S, de Jong D, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005; 207: 243-9.
31. O'Connell RM, Rao DS, Chaudhuri AA, et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008; 205: 585-94.
32. Merkel O, Hamacher F, Laimer D, et al. Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma. Proc Natl Acad Sci USA 2010; 107: 16228-33.
33. Tili E, Croce CM, Michaille JJ,. miR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol 2009; 28: 264-84.
34. Burg G, Kempf W, Haeffner A, et al. From inflammation to neoplasia: new concepts in the pathogenesis of cutaneous lymphomas. Recent Results Cancer Res 2002; 160: 271-80.
35. Roush S, Slack FJ,. The let-7 family of microRNAs. Trends Cell Biol 2008; 18: 505-16.
36. Boyerinas B, Park SM, Hau A, et al. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 2010; 17: F19-36.
37. Garzon R, Pichiorri F, Palumbo T, et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007; 26: 4148-57.
38. Akao Y, Nakagawa Y, Naoe T,. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 2006; 29: 903-6.
39. Ali S, Almhanna K, Chen W, et al. Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am J Transl Res 2010; 3: 28-47.
40. Raponi M, Dossey L, Jatkoe T, et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 2009; 69: 5776-83.
41. Sampson VB, Rong NH, Han J, et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007; 67: 9762-70.
42. Yu F, Yao H, Zhu P, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007; 131: 1109-23.
43. Mezzanzanica D, Bagnoli M, De Cecco L, et al. Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications. Int J Biochem Cell Biol 2010; 42: 1262-72.